<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-109618-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">A non-replicative adenovirus vaccine platform for poultry diseases &#x2013; Phase 2</narrative>
   <narrative xml:lang="FR">Une plateforme pour la mise au point d&#x2019;un vaccin anti-ad&#xE9;novirus non r&#xE9;plicatif contre les maladies aviaires &#x2013; phase 2</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">L&#x2019;&#xE9;levage de volaille en Afrique est l&#x2019;une de plus grandes occasions commerciales du continent. Le poulet est la viande de pr&#xE9;dilection de la plupart des Africains : en effet, un total de 5,7 millions de tonnes de viande de poulet ont &#xE9;t&#xE9; produites en Afrique en 2018, ce qui signifie une augmentation de 4,2 % par rapport &#xE0; 2017. 

La maladie de Newcastle est l&#x2019;une des maladies les plus graves qui touchent la production de volaille en Afrique subsaharienne. Bien que les signalements restent sporadiques sur le continent, certains pays connaissent en moyenne 10 &#xE9;closions de la maladie par an, ce qui nuit consid&#xE9;rablement &#xE0; l&#x2019;&#xE9;conomie locale et &#xE0; la s&#xE9;curit&#xE9; alimentaire. 

Les vaccins inactiv&#xE9;s ou vivants sont disponibles et efficaces, mais pr&#xE9;sentent plusieurs inconv&#xE9;nients bien connus, notamment l&#x2019;excr&#xE9;tion du virus par les oiseaux vaccin&#xE9;s, pouvant contaminer les volailles non vaccin&#xE9;es. Les vaccins contre la maladie de Newcastle actuellement disponibles sont produits dans des &#x153;ufs de poule embryonn&#xE9;s, exempts de pathog&#xE8;nes, chers et import&#xE9;s d&#x2019;Europe. Cette m&#xE9;thode n&#x2019;est pas aussi efficace que les technologies de culture cellulaire et ne se pr&#xEA;te pas &#xE0; une r&#xE9;action rapide en cas de menace de maladie &#xE9;mergente. La premi&#xE8;re phase de ce projet, financ&#xE9; par le Fonds d&#x2019;innovation en vaccins pour le b&#xE9;tail (FIVB) en 2017, visait &#xE0; d&#xE9;velopper un vaccin utilisant un vecteur ad&#xE9;noviral humain non r&#xE9;plicatif. Des &#xE9;tudes pr&#xE9;liminaires de preuve de concept ont r&#xE9;v&#xE9;l&#xE9; des r&#xE9;sultats positifs. L&#x2019;objectif de cette deuxi&#xE8;me phase est d&#x2019;&#xE9;tablir la dose optimale et de parachever l&#x2019;&#xE9;tude de preuve de concept. Cette phase, &#xE9;galement soutenue par le FIVB, permettra de d&#xE9;velopper les proc&#xE9;d&#xE9;s de fabrication d&#x2019;un vaccin recombinant contre la maladie de Newcastle plus s&#xFB;r, plus efficace et plus rentable que les vaccins vivants &#xE0; base d&#x2019;&#x153;ufs. Plus important encore, la m&#xEA;me plateforme technologique a le potentiel d&#x2019;&#xEA;tre d&#xE9;ploy&#xE9;e rapidement pour r&#xE9;pondre &#xE0; d&#x2019;autres menaces virales aviaires. 

Le Fonds d&#x2019;innovation en vaccins pour le b&#xE9;tail est un partenariat entre la Fondation Bill et Melinda Gates, Affaires mondiales Canada et le CRDI. Il repr&#xE9;sente un investissement conjoint de 57 millions de CAD sur cinq ans visant &#xE0; financer le d&#xE9;veloppement, la production et la commercialisation de vaccins innovants contre les maladies du b&#xE9;tail prioritaires en Afrique subsaharienne, en Asie du Sud et en Asie du Sud-Est.</narrative>
   <narrative xml:lang="EN">Poultry farming in Africa is one the biggest business opportunities on the continent. Chicken is the meat of choice for most Africans, with a total of 5.7 million tonnes of chicken meat produced in Africa in 2018, an increase of 4.2% from 2017.  

Newcastle disease is one of the most critical diseases affecting poultry production in sub-Saharan Africa. Although reporting remains sporadic across the continent, some countries average 10 outbreaks per year, which significantly affect the local economy and food security. 
Immunizations with inactivated or live vaccines are available and protective but they have several well-known disadvantages, including virus shedding by vaccinated birds, which can lead to disease in non-vaccinated poultry. The Newcastle disease vaccines that are currently available are produced in speci&#xFB01;c pathogen-free, embryonated chicken eggs that are expensive and imported from Europe. Egg production methods are not efficient compared to cell culture technologies and they are not adapted for rapid response in the case of emerging disease threats. 

The first phase of this project, funded by the Livestock Vaccine Innovation Fund (LVIF) in 2017, sought to develop a vaccine using a non-replicative human adenovirus vector. Preliminary proof of concept studies showed positive results. The aim of this second phase is to establish the optimum dose and finalize the proof-of-concept study. This phase, also supported by LVIF, will develop the manufacturing processes for a recombinant vaccine that is safer, more efficacious, and more cost-effective than the egg-based live Newcastle disease vaccines. More importantly, the same technology platform has the potential to be rapidly deployed to respond to other avian viral threats. 

The Livestock Vaccine Innovation Fund is a partnership of the Bill &amp; Melinda Gates Foundation, Global Affairs Canada, and IDRC. It represents a joint investment of CA$57 million over five years to support the development, production, and commercialization of innovative vaccines against priority livestock diseases in sub-Saharan Africa, South Asia, and Southeast Asia.</narrative>
  </description>
  <participating-org role="1" type="24">
   <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
   <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
  </participating-org>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <participating-org role="2" type="80">
   <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
  </participating-org>
  <participating-org role="4" type="80">
   <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-09-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="2"></activity-scope>
  <recipient-region code="289" percentage="100" vocabulary="1"></recipient-region>
  <sector code="2" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Increasing food security</narrative>
   <narrative xml:lang="FR">S&#xE9;curit&#xE9; alimentaire</narrative>
  </sector>
  <sector code="31182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-19"></transaction-date>
   <value currency="CAD" value-date="2021-01-19">292793.63</value>
   <provider-org>
    <narrative xml:lang="EN">Bill &amp; Melinda Gates Foundation</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-19"></transaction-date>
   <value currency="CAD" value-date="2021-01-19">160328.83</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Affaires mondiales Canada</narrative>
    <narrative xml:lang="EN">Canada. Global Affairs Canada</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-19"></transaction-date>
   <value currency="CAD" value-date="2021-01-19">129577.54</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-01-23"></transaction-date>
   <value currency="CAD" value-date="2021-01-23">19436</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-01-23"></transaction-date>
   <value currency="CAD" value-date="2021-01-23">24049</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-01-23"></transaction-date>
   <value currency="CAD" value-date="2021-01-23">43919</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-09-01"></transaction-date>
   <value currency="CAD" value-date="2021-09-01">151155</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-09-01"></transaction-date>
   <value currency="CAD" value-date="2021-09-01">66894</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2021-09-01"></transaction-date>
   <value currency="CAD" value-date="2021-09-01">82770</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">The Royal Institution for the Advancement of Learning/McGill University</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
